The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis

By Kalliolias George D   C Liossis Stamatis-Nick  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 3, 2008-03 ,pp. : 349-359

Informa Healthcare

Access to resources Recommend Favorite

Clinical pharmacology of tocilizumab for the treatment of systemic juvenile idiopathic arthritis

By Zhang Xiaoping   Morcos Peter N   Saito Tomohisa   Terao Kimio  

Expert Review of Clinical Pharmacology, Vol. 6, Iss. 2, 2013-03 ,pp. : 123-137

Informa Healthcare

Access to resources Recommend Favorite

Tocilizumab takes control of juvenile idiopathic arthritis

By  

Inpharma, Vol. 1, Iss. 1632, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Novel therapies for the treatment of juvenile rheumatoid arthritis (juvenile idiopathic arthritis)

By Agle Lucila MA   Rosenkranz Margalit   Lehman Thomas JA  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 1, 2003-01 ,pp. : 19-28

Informa Healthcare

Access to resources Recommend Favorite

Atopy in children with systemic onset juvenile idiopathic arthritis (SoJIA) is associated with a worse outcome

By Zhang Wen-Ming   Xu Ling-Yun   Lu Yan-ming   Cao Lan-Fang  

Immunopharmacology and Immunotoxicology, Vol. 36, Iss. 2, 2014-04 ,pp. : 176-181

Informa Healthcare

Access to resources Recommend Favorite